Dr. Busby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
48 Centennial Way
Greenville, SC 29605Phone+1 864-522-8000Fax+1 864-522-8005
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2004 - 2007
- University of California Davis HealthResidency, Urology, 2000 - 2004
- University of California Davis HealthResidency, Surgery, 1998 - 2000
- Medical University of South CarolinaClass of 1998
Certifications & Licensure
- CA State Medical License 2000 - Present
- SC State Medical License 2012 - 2025
- AL State Medical License 2007 - 2012
- TX State Medical License 2006 - 2008
- American Board of Urology Urology
Awards, Honors, & Recognition
- America's Top Cancer Doctors Castle Connolly, 2009-2017
- America's Top Doctors Castle Connolly, 2012-2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsEfficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Ph...Vikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, Neal D Shore
The Journal of Urology. 2024-07-01 - 14 citationsAntiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of...Anirban P Mitra, Vikram M Narayan, Sharada Mokkapati, Tanner Miest, Stephen A Boorjian
European Urology. 2022-03-01 - 202 citationsIntravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trialStephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella
The Lancet. Oncology. 2021-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: